These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 12021361)

  • 21. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes.
    Yi Y; Shaheen F; Collman RG
    J Virol; 2005 Feb; 79(3):1480-6. PubMed ID: 15650174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood monocytes harbor HIV type 1 strains with diversified phenotypes including macrophage-specific CCR5 virus.
    Xu Y; Zhu H; Wilcox CK; van't Wout A; Andrus T; Llewellyn N; Stamatatos L; Mullins JI; Corey L; Zhu T
    J Infect Dis; 2008 Jan; 197(2):309-18. PubMed ID: 18173363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.
    Wade J; Sterjovski J; Gray L; Roche M; Chiavaroli L; Ellett A; Jakobsen MR; Cowley D; Pereira Cda F; Saksena N; Wang B; Purcell DF; Karlsson I; Fenyö EM; Churchill M; Gorry PR
    Virology; 2010 Jan; 396(2):246-55. PubMed ID: 19913863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques.
    Vödrös D; Thorstensson R; Doms RW; Fenyö EM; Reeves JD
    Virology; 2003 Nov; 316(1):17-28. PubMed ID: 14599787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
    Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
    Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
    Parrish NF; Wilen CB; Banks LB; Iyer SS; Pfaff JM; Salazar-Gonzalez JF; Salazar MG; Decker JM; Parrish EH; Berg A; Hopper J; Hora B; Kumar A; Mahlokozera T; Yuan S; Coleman C; Vermeulen M; Ding H; Ochsenbauer C; Tilton JC; Permar SR; Kappes JC; Betts MR; Busch MP; Gao F; Montefiori D; Haynes BF; Shaw GM; Hahn BH; Doms RW
    PLoS Pathog; 2012; 8(5):e1002686. PubMed ID: 22693444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An unusual syncytia-inducing human immunodeficiency virus type 1 primary isolate from the central nervous system that is restricted to CXCR4, replicates efficiently in macrophages, and induces neuronal apoptosis.
    Yi Y; Chen W; Frank I; Cutilli J; Singh A; Starr-Spires L; Sulcove J; Kolson DL; Collman RG
    J Neurovirol; 2003 Aug; 9(4):432-41. PubMed ID: 12907388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1.
    Tuttle DL; Harrison JK; Anders C; Sleasman JW; Goodenow MM
    J Virol; 1998 Jun; 72(6):4962-9. PubMed ID: 9573265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins.
    Hill CM; Kwon D; Jones M; Davis CB; Marmon S; Daugherty BL; DeMartino JA; Springer MS; Unutmaz D; Littman DR
    Virology; 1998 Sep; 248(2):357-71. PubMed ID: 9721244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrasting use of CCR5 structural determinants by R5 and R5X4 variants within a human immunodeficiency virus type 1 primary isolate quasispecies.
    Yi Y; Singh A; Shaheen F; Louden A; Lee C; Collman RG
    J Virol; 2003 Nov; 77(22):12057-66. PubMed ID: 14581542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
    Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope.
    Ohagen A; Ghosh S; He J; Huang K; Chen Y; Yuan M; Osathanondh R; Gartner S; Shi B; Shaw G; Gabuzda D
    J Virol; 1999 Feb; 73(2):897-906. PubMed ID: 9882290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.
    Holm GH; Zhang C; Gorry PR; Peden K; Schols D; De Clercq E; Gabuzda D
    J Virol; 2004 May; 78(9):4541-51. PubMed ID: 15078935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
    J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
    Bunnik EM; Quakkelaar ED; van Nuenen AC; Boeser-Nunnink B; Schuitemaker H
    J Virol; 2007 Jan; 81(2):525-31. PubMed ID: 17079299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779.
    Gharu L; Ringe R; Bhattacharya J
    Virus Res; 2011 Jun; 158(1-2):216-24. PubMed ID: 21524671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complexity in human immunodeficiency virus type 1 (HIV-1) co-receptor usage: roles of CCR3 and CCR5 in HIV-1 infection of monocyte-derived macrophages and brain microglia.
    Agrawal L; Maxwell CR; Peters PJ; Clapham PR; Liu SM; Mackay CR; Strayer DS
    J Gen Virol; 2009 Mar; 90(Pt 3):710-722. PubMed ID: 19218218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.